Hemostasis Today

November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Emily Branchard: Uncoupling Anticancer and Antiplatelet Effects of Dipyridamole Analogs
Nov 21, 2026, 08:16

Emily Branchard: Uncoupling Anticancer and Antiplatelet Effects of Dipyridamole Analogs

Emily Branchard, Research Technician at University Health Network, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Nature Cell Death and Disease, adding:

“Excited to share our lab’s latest publication!

Our paper, ‘Dipyridamole analogs uncouple two dipyridamole activities: induction of cancer cell death and inhibition of platelet aggregation,’ has officially been published!

This work explores the development and characterization of dipyridamole analogs to better understand and separate dipyridamole’s anticancer activity from its effects on platelet aggregation, with the goal of identifying compounds with improved therapeutic potential.

I’m proud to have contributed to this project through high-content screening, synergy studies, and various other biological assays that helped evaluate these compounds.

A big congratulations to everyone involved in getting this paper published- lots of hard work and collaboration went into this work.”

Title: Dipyridamole analogs uncouple two dipyridamole activities: induction of cancer cell death and inhibition of platelet aggregation

Authors: Diandra Zipinotti dos Santos, Mohamad Elbaz, Emily Branchard, Taiwo Esan, Carla E. Brown, Autumn R. Meek, Jarkko Ylanko, Justin Kale, David W. Andrews, Mark A. Reed, Peter L. Gross, John K. Buolamwini, Linda Z. Penn

Emily Branchard

Stay updated on all scientific advances with Hemostasis Today.